Mildly symptomatic pulmonary arterial Hypertension Treatment with Bosentan?

被引：0
|
作者：
Halank, M. [1 ]
机构：
[1] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Fetscherstr 74, D-01307 Dresden, Germany
来源：
PNEUMOLOGE | 2009年 / 6卷 / 01期
关键词：
D O I：
10.1007/s10405-008-0273-1
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：35 / +
页数：2
相关论文
共 50 条
  • [1] Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient
    Valerio, Christopher J.
    Coghlan, John G.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 607 - 619
  • [2] Bosentan A Review of its Use in the Management of Mildly Symptomatic Pulmonary Arterial Hypertension
    Dhillon, Sohita
    Keating, Gillian M.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (05) : 331 - 350
  • [3] Bosentan for the treatment of pulmonary arterial hypertension
    Kenyon, KW
    Nappi, JM
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (7-8) : 1055 - 1062
  • [4] Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study):: a double-blind, randomised controlled trial
    Galie, N.
    Rubin, L. J.
    Hoeper, M. M.
    Jansa, P.
    Al-Hiti, H.
    Meyer, G. M. B.
    Chiossi, E.
    Kusic-Pajic, A.
    Simonneau, G.
    [J]. LANCET, 2008, 371 (9630): : 2093 - 2100
  • [5] Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension
    Hatano, Masaru
    Yamada, Hidehiro
    Fukuda, Keiichi
    Yoshioka, Koichiro
    Funauchi, Masanori
    Kuwana, Masataka
    Sata, Masataka
    Taniguchi, Mitsugu
    Nakanishi, Norifumi
    Saito, Takefumi
    Saji, Tsutomu
    Sasayama, Shigetake
    [J]. HEART AND VESSELS, 2015, 30 (06) : 798 - 804
  • [6] Milde symptomatische pulmonal-arterielle HypertonieTherapie mit Bosentan?Mildly symptomatic pulmonary arterial hypertensionTreatment with bosentan?
    M. Halank
    [J]. Der Pneumologe, 2009, 6 (1): : 35 - 36
  • [7] Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension
    Masaru Hatano
    Hidehiro Yamada
    Keiichi Fukuda
    Koichiro Yoshioka
    Masanori Funauchi
    Masataka Kuwana
    Masataka Sata
    Mitsugu Taniguchi
    Norifumi Nakanishi
    Takefumi Saito
    Tsutomu Saji
    Shigetake Sasayama
    [J]. Heart and Vessels, 2015, 30 : 798 - 804
  • [8] Bosentan. Role in the treatment of pulmonary arterial hypertension
    Carlos Grignola, Juan
    Gomez Sanchez, Miguel Angel
    [J]. INSUFICIENCIA CARDIACA, 2009, 4 (01) : 11 - 22
  • [9] Bosentan, hope or reality for the treatment of pulmonary arterial hypertension
    Rubio, JLC
    Centeno, NO
    Martinez, MNB
    Torres-Pujol, JMDH
    [J]. MEDICINA CLINICA, 2004, 123 (04): : 158 - 159
  • [10] Bosentan: A novel agent for the treatment of pulmonary arterial hypertension
    O'Callaghan, D
    Gaine, SP
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (01) : 69 - 73
12345